Lenvatinib and Pembrolizumab for the Treatment of Stage IVB Locally Advanced and Unresectable or Stage IVC Metastatic Anaplastic Thyroid Cancer

NCT04171622 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Thyroid Gland Carcinoma
Poorly Differentiated Thyroid Gland Carcinoma
Stage IVB Thyroid Gland Anaplastic Carcinoma AJCC v8
Stage IVC Thyroid Gland Anaplastic Carcinoma AJCC v8
Thyroid Gland Squamous Cell Carcinoma
Unresectable Thyroid Gland Carcinoma

Interventions

DRUG: Lenvatinib
BIOLOGICAL: Pembrolizumab

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]